Jennifer A. Doudna
Papers
2
Total Citations
27
H-Index
2
About
Jennifer A. Doudna is a pioneering biochemist whose groundbreaking work in CRISPR-Cas9 gene editing has revolutionized molecular biology. Her key research areas encompass CRISPR-Cas9 biology, RNA-guided genome engineering, and the development of novel tools for nucleic acid detection. Doudna is best known for co-discovering the CRISPR-Cas9 system as a programmable gene-editing tool, a breakthrough that has transformed genetic research and therapeutic development. Her major contributions include elucidating the mechanism of CRISPR-Cas9, enabling precise genome modifications in diverse organisms, and advancing applications in medicine and agriculture. With over 100,000 citations across her seminal papers, her work has had an extraordinary impact. Notably, she co-authored the landmark 2012 *Science* paper demonstrating CRISPR-Cas9’s potential, which has garnered tens of thousands of citations. During the COVID-19 pandemic, she adapted her expertise to develop robotic RNA extraction protocols for saliva-based SARS-CoV-2 surveillance, facilitating large-scale asymptomatic testing. Doudna has received numerous honors, including the Nobel Prize in Chemistry (2020) and the Breakthrough Prize in Life Sciences (2015). Her research continues to push boundaries, inspiring a new generation of scientists to explore the frontiers of genome engineering.
Research Focus
Key Achievements
Top Papers
- 1Robotic RNA extraction for SARS-CoV-2 surveillance using saliva samples18 citations · 2021
- 2Robotic RNA extraction for SARS-CoV-2 surveillance using saliva samples9 citations · 2021